Mardi, 11 Décembre 2018
Dernières nouvelles
Principale » Parametric Portfolio Associates LLC Increases Holdings in Inogen, Inc (NASDAQ:INGN)

Parametric Portfolio Associates LLC Increases Holdings in Inogen, Inc (NASDAQ:INGN)

15 Novembre 2017

Crossmark Global Holdings Inc. bought a new position in shares of Inogen during the 3rd quarter valued at about $330,000. Corporate insiders own 5.31% of the company's stock. Blair William & Co/il controls 835,240 shares valued at $79,431,000.

Shares of Inogen, Inc (NASDAQ:INGN) opened at $117.37 on Tuesday. California Public Employees Retirement System raised its stake in shares of Inogen by 8.6% during the 2nd quarter. Quantbot Technologies LP acquired a new position in shares of Inogen during the 2nd quarter worth approximately $529,000. Teacher Retirement System of Texas now owns 2,208 shares of the medical technology company's stock valued at $111,000 after buying an additional 634 shares in the last quarter. Following the transaction, the director now owns 7,808 shares of the company's stock, valued at approximately $734,498.56. Finally, Pacad Investment Ltd. purchased a new position in shares of Inogen during the second quarter valued at about $169,000. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Inogen has a one year low of $59.84 and a one year high of $124.90.

The following firms have recently changed their position in INGN. Zacks Investment Research cut Inogen from a "strong-buy" rating to a "hold" rating in a report on Tuesday, August 8th. The most current P/E ratio is 81.86 and the market cap of the company is 2.43B.

Dimensional Fund Advisors Lp Adjusts Its Stake in Kulicke and Soffa (KLIC)
Its up 0.30, from 1.33 in 2017Q1. 39 funds opened positions while 75 raised stakes. 58,219 were reported by Rhumbline Advisers. Ubs Asset Management Americas Inc expanded its investment by buying 659 shares an increase of 1,318.0% in the quarter.

Inogen (NASDAQ:INGN) last posted its quarterly earnings results on Tuesday, November 7th. Needham & Company LLC reaffirmed a "buy" rating and issued a $108.00 target price on shares of Inogen in a research report on Friday, September 1st. The medical technology company reported $0.33 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.29 by $0.04. Finally, Leerink Swann restated an "outperform" rating and set a $120.00 target price (up from $115.00) on shares of Inogen in a report on Wednesday. The firm had revenue of $69.00 million for the quarter, compared to analysts' expectations of $63.55 million. Inogen had a net margin of 11.36% and a return on equity of 13.37%. During the same quarter past year, the business posted $0.13 EPS. Equities analysts anticipate that Inogen will post $0.62 earnings per share for the current fiscal year. Piper Jaffray Companies reiterated a "hold" rating and issued a $90.00 price objective on shares of Inogen in a report on Tuesday, September 12th. Three investment analysts have rated the stock with a hold rating, three have assigned a buy rating and two have issued a strong buy rating to the company's stock. The company now has a consensus rating of "Buy" and a consensus price target of $103.14. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The total value of its holdings increased 190.9%. The shares were sold at an average price of $94.07, for a total value of $1,316,980.00. Also, Director Raymond Huggenberger sold 14,000 shares of the business's stock in a transaction that occurred on Monday, October 16th. Following the completion of the transaction, the executive vice president now directly owns 6,964 shares in the company, valued at $643,821.80. The disclosure for this sale can be found here. Insiders have sold 53,000 shares of company stock valued at $5,140,630 in the last ninety days.

ILLEGAL ACTIVITY NOTICE: "Parametric Portfolio Associates LLC Increases Holdings in Inogen, Inc (NASDAQ:INGN)" was originally published by StockNewsTimes and is the sole property of of StockNewsTimes.